BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31912590)

  • 1. Accuracy of SCORTEN to predict the prognosis of Stevens-Johnson syndrome/toxic epidermal necrolysis: a systematic review and meta-analysis.
    Torres-Navarro I; Briz-Redón Á; Botella-Estrada R
    J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):2066-2077. PubMed ID: 31912590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic therapies for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: a SCORTEN-based systematic review and meta-analysis.
    Torres-Navarro I; Briz-Redón Á; Botella-Estrada R
    J Eur Acad Dermatol Venereol; 2021 Jan; 35(1):159-171. PubMed ID: 32946187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of SCORTEN and ABCD-10 to predict mortality and the influence of renal function in Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Torres-Navarro I; Briz-Redón Á; Botella-Casas G; Sahuquillo-Torralba A; Calle-Andrino A; de Unamuno-Bustos B; Piqueras-García J; Roca Ginés J; Magdaleno Tapial J; Alegre de Miquel V; Botella-Estrada R
    J Dermatol; 2020 Oct; 47(10):1182-1186. PubMed ID: 32856355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing the Accuracy of ABCD-10 and SCORTEN in Predicting the In-Hospital Mortality of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Multi-Institutional Study from Central China.
    Suo H; Jiang B; Sun X; Dong J; Alamgir M; Guan X; Su H; Liu Y; Xia Y; Zhou N; Feng A; Tao J
    Dermatology; 2022; 238(4):736-744. PubMed ID: 34875648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinicotherapeutic analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis with an emphasis on the predictive value and accuracy of SCORe of Toxic Epidermal Necrolysis.
    Bansal S; Garg VK; Sardana K; Sarkar R
    Int J Dermatol; 2015 Jan; 54(1):e18-26. PubMed ID: 25534407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinico- Therapeutic Study of Stevens Johnson Syndrome-Toxic Epidermal Necrolysis and Prognostic Significance of SCORTEN in Indian Patients.
    Jangid NC; Choudhary AN; Shah BJ; Shah SR; Vyas HR; Mistry D
    Indian J Dermatol; 2024; 69(1):24-31. PubMed ID: 38572027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis-ABCD-10.
    Noe MH; Rosenbach M; Hubbard RA; Mostaghimi A; Cardones AR; Chen JK; Cotliar J; Davis MDP; Dominguez A; Fox LP; Hughey LC; Kaffenberger BH; Kroshinsky D; Kwong BY; Miller DD; Musiek A; Ortega-Loayza AG; Sharon VR; Shinkai K; Summers EM; Wanat KA; Wetter DA; Worswick S; Margolis DJ; Gelfand JM; Micheletti RG
    JAMA Dermatol; 2019 Apr; 155(4):448-454. PubMed ID: 30840032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of ABCD-10 and SCORTEN mortality prediction models in a cohort of patients with Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Duplisea MJ; Roberson ML; Chrisco L; Strassle PD; Williams FN; Ziemer CM
    J Am Acad Dermatol; 2021 Oct; 85(4):873-877. PubMed ID: 33940101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN.
    Morales ME; Purdue GF; Verity SM; Arnoldo BD; Blomquist PH
    Am J Ophthalmol; 2010 Oct; 150(4):505-510.e1. PubMed ID: 20619392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment and Comparison of Performance of ABCD-10 and SCORTEN in Prognostication of Epidermal Necrolysis.
    Koh HK; Fook-Chong S; Lee HY
    JAMA Dermatol; 2020 Dec; 156(12):1294-1299. PubMed ID: 33084873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cohort study of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis in China: evaluation of risk models and new predictor of pulmonary consolidation on computed tomography.
    Shou Y; Yang L; Yang Y; Zhu X; Li F; Yin B; Zheng Y; Xu J
    Front Med; 2021 Aug; 15(4):585-593. PubMed ID: 33644844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of histologic features of toxic epidermal necrolysis.
    Valeyrie-Allanore L; Bastuji-Garin S; Guégan S; Ortonne N; Bagot M; Roujeau JC; Revuz JE; Wechsler J; Wolkenstein P
    J Am Acad Dermatol; 2013 Feb; 68(2):e29-35. PubMed ID: 22088428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil : lymphocyte ratio is associated with disease severity and mortality in patients with Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Wang Q; Lan YP; Qi B; Yin L; Zhang LX; Liu W
    J Dermatol; 2021 Sep; 48(9):1394-1400. PubMed ID: 34060656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China.
    Yang Y; Xu J; Li F; Zhu X
    Int J Dermatol; 2009 Oct; 48(10):1122-8. PubMed ID: 19775409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose intravenous immunoglobulins in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese patients: a retrospective study of 82 cases.
    Chen J; Wang B; Zeng Y; Xu H
    Eur J Dermatol; 2010; 20(6):743-7. PubMed ID: 20952352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How Does SCORTEN Score?
    Zavala S; O'Mahony M; Joyce C; Baldea AJ
    J Burn Care Res; 2018 Jun; 39(4):555-561. PubMed ID: 29789855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of SCORTEN on a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis included in the RegiSCAR study.
    Sekula P; Liss Y; Davidovici B; Dunant A; Roujeau JC; Kardaun S; Naldi L; Schumacher M; Mockenhaupt M
    J Burn Care Res; 2011; 32(2):237-45. PubMed ID: 21228709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review of treatments for Stevens-Johnson syndrome and toxic epidermal necrolysis using the SCORTEN score as a tool for evaluating mortality.
    Roujeau JC; Bastuji-Garin S
    Ther Adv Drug Saf; 2011 Jun; 2(3):87-94. PubMed ID: 25083204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal necrolysis: SCORTEN performance in AIDS and non-AIDS patients.
    Wambier CG; Hoekstra TA; Wambier SPF; Bueno Filho R; Vilar FC; Paschoal RS; Roselino AM; Frade MAC; Foss NT
    An Bras Dermatol; 2019; 94(1):17-23. PubMed ID: 30726458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicoetiological Study of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Spectrum and the Correlation of SCORTEN with Prognosis.
    Kanagarajan A; Murthy AB; Moni PK; Palanivel N
    Indian J Dermatol; 2023; 68(1):25-33. PubMed ID: 37151260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.